Publications by authors named "Glenn Liu"

100Publications

Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate Cancer.

Clin Genitourin Cancer 2019 08 27;17(4):306-314. Epub 2019 May 27.

Department of Medical Physics, University of Wisconsin, Madison, WI; University of Wisconsin Carbone Cancer Center, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.05.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331881PMC
August 2019

FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab.

J Immunother Cancer 2019 01 30;7(1):23. Epub 2019 Jan 30.

University of Wisconsin Carbone Cancer Center, 1111 Highland Ave, Madison, WI, 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0516-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354338PMC
January 2019

Response-to-repeatability of quantitative imaging features for longitudinal response assessment.

Phys Med Biol 2019 01 18;64(2):025019. Epub 2019 Jan 18.

Department of Medical Physics, University of Wisconsin, Madison, WI, United States of America.

View Article

Download full-text PDF

Source
http://iopscience.iop.org/article/10.1088/1361-6560/aafa0a
Publisher Site
http://dx.doi.org/10.1088/1361-6560/aafa0aDOI Listing
January 2019

Automated classification of benign and malignant lesions in F-NaF PET/CT images using machine learning.

Phys Med Biol 2018 11 20;63(22):225019. Epub 2018 Nov 20.

Department of Medical Physics, University of Wisconsin, Madison, WI, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/aaebd0DOI Listing
November 2018

A statistically optimized regional thresholding method (SORT) for bone lesion detection in F-NaF PET/CT imaging.

Phys Med Biol 2018 11 20;63(22):225018. Epub 2018 Nov 20.

Department of Medical Physics, University of Wisconsin, Madison, WI, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/aaebbaDOI Listing
November 2018

Reply to I.F. Tannock, P. Isaacsson Velho et al, R.Z. Szmulewitz et al, M. Tiako Meyo et al, and F.J.S.H. Woei-A-Jin et al.

J Clin Oncol 2018 10 6;36(30):3065-3066. Epub 2018 Sep 6.

Jill M. Kolesar, University of Kentucky, Lexington, KY; and Glenn Liu, University of Wisconsin-Madison, Madison, WI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.79.3208
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.79.3208DOI Listing
October 2018

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline.

J Clin Oncol 2018 Nov 5;36(32):3251-3258. Epub 2018 Sep 5.

Justin E. Bekelman and Neha Vapiwala, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Ronald C. Chen, University of North Carolina at Chapel Hill, Chapel Hill; Stephen J. Freedland, Durham VA Medical Center, Durham, NC; Thomas M. Pisansky, Mayo Clinic, Rochester, MN; Antonio Finelli, Princess Margaret Cancer Centre, University Health Network; Andrew Feifer, Trillium Health Partners, University of Toronto; D. Andrew Loblaw, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Paul L. Nguyen, Dana-Farber Cancer Institute, Boston, MA; Scott T. Tagawa, Weill Cornell Medicine, New York, NY; Silke Gillessen, Kantonsspital St Gallen, St Gallen, Switzerland; Todd M. Morgan, University of Michigan, Ann Arbor, MI; Glenn Liu, University of Wisconsin Carbone Cancer Center, Madison, WI; John J. Haluschak, Kettering Medical Center-Pavillon, Kettering; Andrew Stephenson, Cleveland Clinic, Cleveland, OH; Karim Touijer, Memorial Sloan Kettering Cancer Center, New York, NY; Terry Kungel, Maine Coalition to Fight Prostate Cancer, Augusta, ME; and Stephen J. Freedland, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00606
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00606DOI Listing
November 2018

Dynamic F-FLT PET imaging of spatiotemporal changes in tumor cell proliferation and vasculature reveals the mechanistic actions of anti-angiogenic therapy.

Phys Med Biol 2018 07 27;63(15):155008. Epub 2018 Jul 27.

Department of Medical Physics, University of Wisconsin, 1111 Highland Ave, Madison, WI 53792, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/aad1beDOI Listing
July 2018

Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel.

Cancer Chemother Pharmacol 2018 08 25;82(2):211-219. Epub 2018 May 25.

University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, WIMR Room 7105, 1111 Highland Avenue, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3599-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205037PMC
August 2018

Low-Fat Abiraterone Food Effect Is of Little Consequence.

J Clin Oncol 2018 05 28;36(14):1385-1386. Epub 2018 Mar 28.

Jill M. Kolesar, University of Kentucky, Lexington, KY; and Glenn X. Liu, University of Wisconsin-Madison, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.0684DOI Listing
May 2018

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.

J Clin Oncol 2018 04 31;36(11):1080-1087. Epub 2018 Jan 31.

Christos E. Kyriakopoulos, Glenn Liu, and David F. Jarrard, University of Wisconsin (UW) School of Medicine and Public Health and UW Carbone Cancer Center, Madison, WI; Yu-Hui Chen and Christopher J. Sweeney, Dana-Farber Cancer Institute; Yu-Hui Chen, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group; Christopher J. Sweeney, Harvard Medical School, Boston, MA; Michael A. Carducci, Noah M. Hahn, and Mario Eisenberger, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD; Daniel H. Shevrin, NorthShore University HealthSystem, Evanston; Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; Robert Dreicer, University of Virginia Cancer Center, Charlottesville, VA; Manish Kohli, Mayo Clinic, Rochester, MN; Elizabeth R. Plimack, Fox Chase Cancer Center, Temple Health, Philadelphia, PA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Joel Picus, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO; Matthew M. Cooney, Seidman Cancer Center, University Hospitals Cleveland Medical Center; Jorge A. Garcia, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; and Robert S. DiPaola, University of Kentucky College of Medicine, Lexington, KY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.3657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891129PMC
April 2018

Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.

J Clin Oncol 2018 02 20;36(4):376-382. Epub 2017 Dec 20.

Lauren C. Harshman and Christopher J. Sweeney, Dana-Farber Cancer Institute, Harvard Medical School; Yu-Hui Chen, Dana-Farber Cancer Institute, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group, Boston, MA; Glenn Liu and David Jarrard, University of Wisconsin School of Medicine and Public Health and Carbone Cancer Center, Madison, WI; Michael A. Carducci, Noah Hahn, and Mario Eisenberger, Johns Hopkins University, Baltimore, MD; Robert Dreicer, University of Virginia Cancer Center, Charlottesville, VA; Jorge A. Garcia, Cleveland Clinic Taussig Cancer Institute; Matthew Cooney, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, OH; Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago; Daniel Shevrin, NorthShore University Health System, Evanston, IL; Manish Kohli, Mayo Clinic, Rochester, MN; Elizabeth R. Plimack, Fox Chase Cancer Center, Temple Health, Philadelphia, PA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Joel Picus, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO; and Robert Dipaola, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.75.3921
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.75.3921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805480PMC
February 2018

Quantitative Assessment of Early [F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone.

J Clin Oncol 2017 Aug 27;35(24):2829-2837. Epub 2017 Jun 27.

Stephanie A. Harmon, Timothy Perk, Christie Lin, Jens Eickhoff, Glenn Liu, and Robert Jeraj, University of Wisconsin-Madison; Glenn Liu and Robert Jeraj, Prostate Cancer Clinical Trials Consortium, Madison, WI; Peter L. Choyke, William L. Dahut, and Andrea B. Apolo, National Cancer Institute, Bethesda, MD; John L. Humm, Steven M. Larson, and Michael J. Morris, Memorial Sloan Kettering Cancer Center; and Steven M. Larson and Michael J. Morris, Prostate Cancer Clinical Trials Consortium, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562173PMC
August 2017

ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.

Mol Pharm 2017 05 12;14(5):1782-1789. Epub 2017 Apr 12.

Department of Medical Physics, University of Wisconsin-Madison , Madison, Wisconsin 53705, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.molpharmaceut.7b00056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495656PMC
May 2017

A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors.

Invest New Drugs 2017 06 21;35(3):290-297. Epub 2016 Dec 21.

University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI, 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0418-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809175PMC
June 2017

F-FLT PET/CT imaging in patients with advanced solid malignancies treated with axitinib on an intermittent dosing regimen.

Cancer Chemother Pharmacol 2016 Dec 5;78(6):1245-1252. Epub 2016 Nov 5.

Department of Medical Physics, Wisconsin Institute for Medical Research, University of Wisconsin, Room 1005, 1111 Highland Ave, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3183-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209788PMC
December 2016

Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A Review.

Cancer J 2016 Sep/Oct;22(5):322-325

From the University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000215DOI Listing
August 2017

Utilization and evaluation of noncore chemotherapy regimens within an academic medical center.

J Oncol Pharm Pract 2017 Oct 6;23(7):518-524. Epub 2016 Jul 6.

2 University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155216657679DOI Listing
October 2017

Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer.

Clin Cancer Res 2016 06 29;22(11):2659-67. Epub 2016 Mar 29.

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891227PMC
June 2016

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

J Clin Oncol 2016 Apr 22;34(12):1402-18. Epub 2016 Feb 22.

Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.2702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872347PMC
April 2016

A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2016 Mar 20;77(3):527-38. Epub 2016 Jan 20.

Wisconsin Institute for Medical Research, University of Wisconsin Carbone Cancer Center, Room 7105, 1111 Highland Avenue, Madison, WI, 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-2958-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849384PMC
March 2016

PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.

J Nucl Med 2016 Feb 5;57(2):285-90. Epub 2015 Nov 5.

Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin; and University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.166462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738068PMC
February 2016

Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.

Nucl Med Commun 2015 Dec;36(12):1174-80

aJozef Stefan Institute, Ljubljana, Slovenia Departments of bMedical Physics cRadiology dGenitourinary Oncology Research Program eUniversity of Wisconsin Carbone Cancer Center, University of Wisconsin - Madison, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626289PMC
December 2015

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

N Engl J Med 2015 Aug 5;373(8):737-46. Epub 2015 Aug 5.

From the Department of Medicine (C.J.S.) and the Department of Biostatistics and Computational Biology (Y.-H.C.), Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston (C.J.S.); Johns Hopkins University, Baltimore (M.C., M.E.); University of Wisconsin Carbone Cancer Center (G.L., D.F.J.) and School of Medicine and Public Health (D.F.J.), Madison; Fox Chase Cancer Center, Temple University Health System, Philadelphia (Y.-N.W.); Indiana University Melvin and Bren Simon Cancer Center, Indianapolis (N.H.); Mayo Clinic, Rochester, MN (M.K.); University Hospitals Case Medical Center, Seidman Cancer Center (M.M.C.), and Cleveland Clinic Taussig Cancer Institute (J.A.G.) - both in Cleveland; University of Virginia Cancer Center, Charlottesville (R.D.); Comprehensive Cancer Centers of Nevada, Las Vegas (N.J.V.); Siteman Cancer Center, Washington University School of Medicine, St. Louis (J.P.); NorthShore University HealthSystem, Evanston, IL (D.S.); University of Michigan Comprehensive Cancer Center, Ann Arbor (M.H.); and Rutgers Cancer Institute of New Jersey, New Brunswick (R.S.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1503747DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562797PMC
August 2015

Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography.

Cancer Chemother Pharmacol 2015 Jul 29;76(1):187-95. Epub 2015 May 29.

Department of Medicine, University of Wisconsin Carbone Cancer Center, 7105 Wisconsin Institute Medical Research, 1111 Highland Ave, Madison, WI, 53705, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2779-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499265PMC
July 2015

Potential cytochrome P-450 drug-drug interactions in adults with metastatic solid tumors and effect on eligibility for Phase I clinical trials.

Am J Health Syst Pharm 2015 Jun;72(11):958-65

Kari B. Wisinski, M.D., is Assistant Professor of Medicine, School of Medicine and Public Health, University of Wisconsin (UW), Madison, and Assistant Professor, UW Carbone Cancer Center, Madison. Colby A. Cantu, B.S., is Medical Student, School of Medicine and Public Health, UW. Jens Eickhoff, Ph.D., is Senior Scientist, Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, UW. Kurt Osterby, B.S., is Senior Decision Support Analyst, UW Hospital and Clinics, Madison. Amye J. Tevaarwerk, M.D., is Assistant Professor of Medicine, School of Medicine and Public Health, UW, and Assistant Professor, UW Carbone Cancer Center. Jennifer Heideman, R.N., is Program Manager, School of Medicine and Public Health, UW, and Program Manager, UW Carbone Cancer Center. Glenn Liu, M.D., is Associate Professor of Medicine, School of Medicine and Public Health, UW, and UW Carbone Cancer Center. George Wilding, M.D., is Professor of Medicine, School of Medicine and Public Health, UW, and Professor, UW Carbone Cancer Center. Susan Johnston, Pharm.D., is Pharmaceutical Research Center Manager, UW Carbone Cancer Center, and UW Hospital and Clinics. Jill M. Kolesar, Pharm.d., is Professor of Pharmacy, School of Pharmacy, UW, and Faculty Supervisor, Analytical Laboratory for Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics, UW Carbone Cancer Center.

View Article

Download full-text PDF

Source
http://www.ajhp.org/cgi/doi/10.2146/ajhp140591
Publisher Site
http://dx.doi.org/10.2146/ajhp140591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510955PMC
June 2015

Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients.

Am J Nucl Med Mol Imaging 2015 15;5(2):162-8. Epub 2015 Jan 15.

Department of Radiology, Division of Nuclear Medicine, University of Wisconsin Madison Madison, WI, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396008PMC
May 2015

Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.

Clin Genitourin Cancer 2015 Feb 15;13(1):e7-e17. Epub 2014 Jul 15.

Jozef Stefan Institute, Ljubljana, Slovenia; Department of Medical Physics, University of Wisconsin-Madison, Madison, WI; Department of Radiology, University of Wisconsin-Madison, Madison, WI; Centre of Excellence for Biosensors, Instrumentation and Process Control (COBIK), Ajdovscina, Slovenia; University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289415PMC
February 2015

Imaging of castration-resistant prostrate cancer: development of imaging response biomarkers.

Curr Opin Urol 2013 May;23(3):230-6

Department of Medical Physics, University of Wisconsin, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0b013e32835e9edcDOI Listing
May 2013

Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib.

Clin Genitourin Cancer 2013 Jun 4;11(2):107-14. Epub 2013 Feb 4.

Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2012.12.004DOI Listing
June 2013

Current controversies in the management of biochemical failure in prostate cancer.

Clin Adv Hematol Oncol 2012 Nov;10(11):716-22

Division of Hematology/Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53705-2275, USA.

View Article

Download full-text PDF

Source
November 2012

Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.

Eur J Nucl Med Mol Imaging 2012 Jan 10;39(1):138-48. Epub 2011 Sep 10.

Department of Radiology, University of Wisconsin-Madison, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-011-1930-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228902PMC
January 2012

In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis.

Eur J Nucl Med Mol Imaging 2011 Nov 4;38(11):2066-76. Epub 2011 Aug 4.

Department of Radiology, University of Wisconsin-Madison, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-011-1886-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189267PMC
November 2011

Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.

Cancer 2011 Jun 14;117(12):2629-36. Epub 2010 Dec 14.

Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25824DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064951PMC
June 2011

A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumors.

Invest New Drugs 2012 Jun 22;30(3):1088-95. Epub 2011 Mar 22.

University of Wisconsin Carbone Cancer Center, 600 Highland Ave., Madison, WI 53792-5666, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-011-9653-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394096PMC
June 2012

A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate.

Invest New Drugs 2012 Apr 22;30(2):794-802. Epub 2010 Dec 22.

Section of Hematology/Oncology, University of Wisconsin Carbone Cancer Center, Wisconsin Institutes for Medical Research, Room 7105, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-010-9618-9
Publisher Site
http://dx.doi.org/10.1007/s10637-010-9618-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191229PMC
April 2012

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors.

Cancer Chemother Pharmacol 2011 Feb 13;67(2):305-14. Epub 2010 Apr 13.

University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, 3103 WIMR, 1111 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1318-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050703PMC
February 2011

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study.

Cancer Chemother Pharmacol 2010 Sep 31;66(4):669-80. Epub 2009 Dec 31.

Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1209-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904454PMC
September 2010

Response to antiangiogenesis therapy in a patient with advanced adult-type testicular granulosa cell tumor.

Oncology (Williston Park) 2009 Aug;23(9):792-5

Section of Hematology/Oncology, Department of Medicine, University of Wisconsin, UW Carbone Cancer Center, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437818PMC
August 2009

A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer.

Invest New Drugs 2011 Feb 19;29(1):118-25. Epub 2009 Sep 19.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, 600 Highland Avenue, K6/534 CSC, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9318-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008512PMC
February 2011

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

J Clin Oncol 2009 Sep 27;27(25):4047-54. Epub 2009 Jul 27.

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Department of Biostatistics, University of Wisconsin, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.9968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734418PMC
September 2009

Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.

Clin Adv Hematol Oncol 2009 Jan;7(1):54-64

University of Wisconsin Hospital and Clinics, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904974PMC
January 2009

Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.

Clin Cancer Res 2009 Feb;15(4):1460-5

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892631PMC
February 2009

Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.

Clin Cancer Res 2008 Dec;14(23):7924-9

Institute for Drug Development, Cancer Therapy and Research Center and The University of Texas Health Science Center at San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394092PMC
December 2008

ZD4054: a specific endothelin A receptor antagonist with promising activity in metastatic castration-resistant prostate cancer.

Expert Opin Investig Drugs 2008 Aug;17(8):1237-45

University of Wisconsin School of Medicine and Public Health, Health Sciences Learning Center, 750 Highland Avenue, Madison, WI 53705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.17.8.1237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908530PMC
August 2008

Endothelin receptor antagonists in cancer therapy.

Cancer Invest 2007 Dec;25(8):785-94

Genitourinary Oncology Research Group, University of Wisconsin, Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900701522588DOI Listing
December 2007